The results described by Choi and collaborators provide a mechanism by which ST3 bacteria evade the antibody response, showing that the high concentrations of CPS3 released by ST3 pneumococci during infection compete for the anti‐PS3 antibodies induced by vaccines and support the hypothesis that protection against ST3 requires higher levels of antibodies. The gene discussed is TAS2R6P; the disease is infection.